A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer-Reference-Cited by-同舟云学术

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer

Published:2003-01 Issue:1 Volume:39 Page:55-61
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Massarelli E,Andre F,Liu D.D,Lee J.J,Wolf M,Fandi A,Ochs J,Le Chevalier T,Fossella F,Herbst R.S

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference17 articles.

1. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results;Breathnach;J. Clin. Oncol.,2001

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Br Med J,1995

3. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer;Schiller;N. Engl. J. Med.,2002

4. Locally advanced, unresectable non-small cell lung cancer: new treatment strategies;Johnson;Chest,2000

5. Management issues for stage IV non-small cell lung cancer;Earle;Cancer Control,1997

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic molecular targets for better outcomes for patients with lung cancer;International Journal of Molecular and Immuno Oncology;2023-06-03

2. Pembrolizumab plus lenvatinib as first-line therapy for patients with mismatch repair-proficient advanced endometrial cancer: A United States-based cost-effectiveness analysis;Gynecologic Oncology;2022-09

3. Improving trial generalizability using observational studies;Biometrics;2022-01-11

4. Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy;Cancer Research and Treatment;2021-11-17

5. Phase I/II study of biweekly nab‐paclitaxel in patients with platinum‐pretreated non‐small cell lung cancer: NJLCG1402;Thoracic Cancer;2021-09-14